EasyDNA Launches Non-Invasive Prenatal Testing (NIPT) to Support Early Pregnancy Screening
International health testing provider EasyDNA introduces Non-Invasive Prenatal Testing (NIPT), an advanced prenatal screening solution designed to provide expectant parents with early insights into their baby’s health through a simple and non-invasive blood test.
EasyDNA, a trusted provider of health and wellness testing services, has announced the launch of its Non-Invasive Prenatal Testing (NIPT), offering expectant parents a safe, accurate, and convenient prenatal screening option available from as early as 10 weeks into pregnancy.
NIPT is an advanced screening test that analyses small fragments of fetal DNA present in the mother’s bloodstream to assess the likelihood of certain chromosomal conditions, including Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and Patau syndrome (Trisomy 13). The test provides valuable early insights that can help parents make informed decisions alongside their healthcare professionals.
A spokesperson for EasyDNA shared:
“Pregnancy is an important and emotional journey, and many expectant parents seek reassurance and clarity during this time. Our NIPT service is designed to provide accurate and accessible prenatal screening information in a simple and non-invasive way, helping families feel more informed and supported throughout their pregnancy.”
Unlike invasive prenatal procedures, NIPT only requires a maternal blood sample, making the process safer and more comfortable for expectant mothers. The screening test is suitable for a wide range of pregnancies, including singleton and certain twin pregnancies, and can be completed through a straightforward sample collection process.
The EasyDNA NIPT service has been developed to combine advanced laboratory analysis with convenience and accessibility. Following laboratory processing, results are typically available within a few working days, allowing parents to receive timely insights during the early stages of pregnancy.
As awareness surrounding prenatal health continues to grow globally, more families are seeking reliable and less invasive screening options. The launch of NIPT reflects EasyDNA’s continued commitment to expanding access to modern health testing services that prioritise accuracy, customer care, and ease of use.
While NIPT is highly accurate, EasyDNA emphasises that the test is a screening tool rather than a diagnostic test. Any high-risk or unexpected results should be discussed with a qualified healthcare professional, who may recommend additional diagnostic testing where appropriate.
About EasyDNA
EasyDNA is a leading provider of DNA testing services, offering a wide range of tests including Paternity DNA testing, Relationship DNA testing and Prenatal DNA testing, as well as other tests such as Clinical DNA testing, Health testing, and Ancestry testing services. Over the last decade, the company has handled thousands of DNA tests through internationally accredited laboratories holding the highest international accreditations.
